To a full room of attendees for the “Applying 3D Models for Toxicological Research” track of the 14th Annual World Preclinical Congress (WPC) in Boston, Asymmetrex Director James L. Sherley, M.D., Ph.D. explained how giving more attention to tissue stem cell dynamics could bring greater improvements to the physiological relevance of tissue-engineered systems for drug development. Sherley explained how even in traditional 2D cell culture systems that may lack important 3D physical elements, analyses of the “third dimension of time” gave Asymmetrex innovative technologies for evaluating the effects of drug candidates on tissues of the body.
(PRWeb June 16, 2015)
Read the full story at http://www.prweb.com/releases/2015/06/prweb12790827.htm
For more information, please visit
http://www.prweb.com/releases/2015/06/prweb12790827.htm